Concepedia

Anna E. Maciag

AE

2

Publications

46

Citations

2

H-Index

2024

Active since

Affiliations

Lawrence Livermore National Laboratory(Current)

National Cancer Institute

BridgeBio (United States)

Frederick National Laboratory for Cancer Research

University of California, San Francisco

Anna E. Maciag is an author at Lawrence Livermore National Laboratory specializing in molecular docking, drug discovery, and tumor biology.

Top concepts

MedicineBiochemistryCell BiologyTumor BiologyCell SignalingDrug DiscoverySystems BiologyNatural SciencesMolecular BiologyMolecular Docking

Publications per year

2024–2025

2

Publications

2

Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C

Anna E. Maciag, James P. Stice, Bin Wang et al. · Cancer Discovery · 2024 · 33 citations · Full text

Molecular Biology, Direct Target Coverage, Adaptive Resistance +19

BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction

Dhirendra K. Simanshu, Rui Xu, James P. Stice et al. · Science · 2025 · 13 citations

Rows per page

1–2 of 2